Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO
Madison, Wis . - In a merging of complementary companies, Cytochroma, Inc ., a Canadian firm seeking to commercialize new Vitamin D products, has acquired Proventiv
Therapeutics, LLC, of Madison, and the combined company is looking for an additional $25 million in venture capital from Canadian an...
Genzyme sues former Bone Care employees
...ly for an estimated $600 million. The former employees, Charles Bishop, Keith Crawford and Eric Messner, left Genzyme and started a new company called proventiv
Therapeutics, LLC, in September of 2005.
Proventiv recently was purchased by Cytochroma, a Markham, Ontario-based company that develops products to...
Biotech with Madison ties raises $21M in capital
... Madison, Wis. - When Cytochroma , a Canadian firm seeking to commercialize new vitamin D products, acquired the Madison-based proventiv
Therapeutics last year, executives indicated that the combined company was looking for an additional $25 million in venture capital from Canadian and ...
Cytochroma settles lawsuit with Genzyme
Genzyme filed the suit in August of 2006 against Cytochroma Inc., proventiv
Therapeutics, LLC, and the three former Bone Care International employees. ... Care employees - Charles Bishop, Keith Crawford, and Eric Messner - formed proventiv
Therapeutics, which was acquired by Cytochroma in 2006.
Cytochroma is a ...